161 related articles for article (PubMed ID: 34995974)
1. Arterial enhancement pattern predicts survival in patients with resectable and unresectable intrahepatic cholangiocarcinoma.
Panettieri E; Maki H; Kim BJ; Kang HC; Cox V; Vega EA; Mizuno T; Pant S; Javle M; Vauthey JN; Kawaguchi Y
Surg Oncol; 2022 Mar; 40():101696. PubMed ID: 34995974
[TBL] [Abstract][Full Text] [Related]
2. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.
Gusani NJ; Balaa FK; Steel JL; Geller DA; Marsh JW; Zajko AB; Carr BI; Gamblin TC
J Gastrointest Surg; 2008 Jan; 12(1):129-37. PubMed ID: 17851723
[TBL] [Abstract][Full Text] [Related]
3. The favorable prognosis after operative resection of hypervascular intrahepatic cholangiocarcinoma: A clinicopathologic and immunohistochemical study.
Türkoğlu MA; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Uemura S; Miyata T; Kakuda Y; Nakanuma Y; Uesaka K
Surgery; 2016 Sep; 160(3):683-90. PubMed ID: 27155908
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakamura H; Nakashima A; Sueda T
J Gastrointest Surg; 2009 Aug; 13(8):1470-9. PubMed ID: 19421824
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy is associated with improved survival in patients undergoing hepatic resection for intrahepatic cholangiocarcinoma.
Sutton TL; Billingsley KG; Walker BS; Enestvedt CK; Dewey EN; Orloff SL; Mayo SC
Am J Surg; 2021 Jun; 221(6):1182-1187. PubMed ID: 33707077
[TBL] [Abstract][Full Text] [Related]
6. Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes.
Ariizumi S; Kotera Y; Takahashi Y; Katagiri S; Chen IP; Ota T; Yamamoto M
J Surg Oncol; 2011 Aug; 104(2):130-9. PubMed ID: 21448898
[TBL] [Abstract][Full Text] [Related]
7. Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis.
Reames BN; Bagante F; Ejaz A; Spolverato G; Ruzzenente A; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
HPB (Oxford); 2017 Oct; 19(10):901-909. PubMed ID: 28728891
[TBL] [Abstract][Full Text] [Related]
8. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
[TBL] [Abstract][Full Text] [Related]
9. Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma.
Nanashima A; Sumida Y; Abo T; Oikawa M; Murakami G; Takeshita H; Fukuoka H; Hidaka S; Nagayasu T; Sakamoto I; Sawai T
J Surg Oncol; 2008 Dec; 98(7):535-9. PubMed ID: 18814285
[TBL] [Abstract][Full Text] [Related]
10. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.
Wang JJ; Li H; Li JX; Xu L; Wu H; Zeng Y
World J Gastroenterol; 2020 Apr; 26(13):1501-1512. PubMed ID: 32308350
[TBL] [Abstract][Full Text] [Related]
11. Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.
Konstantinidis IT; Groot Koerkamp B; Do RK; Gönen M; Fong Y; Allen PJ; D'Angelica MI; Kingham TP; DeMatteo RP; Klimstra DS; Kemeny NE; Jarnagin WR
Cancer; 2016 Mar; 122(5):758-65. PubMed ID: 26695839
[TBL] [Abstract][Full Text] [Related]
12. Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.
Camacho JC; Kokabi N; Xing M; Prajapati HJ; El-Rayes B; Kim HS
J Vasc Interv Radiol; 2014 Feb; 25(2):256-65. PubMed ID: 24461131
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of tumor vascularity on CT in resectable intrahepatic cholangiocarcinoma.
Park HM; Jang HY; Lee DE; Kang MJ; Han SS; Kim SW; Park SJ
HPB (Oxford); 2022 Mar; 24(3):359-369. PubMed ID: 34325966
[TBL] [Abstract][Full Text] [Related]
14. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.
Rayar M; Sulpice L; Edeline J; Garin E; Levi Sandri GB; Meunier B; Boucher E; Boudjema K
Ann Surg Oncol; 2015 Sep; 22(9):3102-8. PubMed ID: 25623598
[TBL] [Abstract][Full Text] [Related]
15. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
[No Abstract] [Full Text] [Related]
16. Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers.
Xu J; Igarashi S; Sasaki M; Matsubara T; Yoneda N; Kozaka K; Ikeda H; Kim J; Yu E; Matsui O; Nakanuma Y
Liver Int; 2012 Aug; 32(7):1156-64. PubMed ID: 22417172
[TBL] [Abstract][Full Text] [Related]
17. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes.
Kim JH; Yoon HK; Sung KB; Ko GY; Gwon DI; Shin JH; Song HY
Cancer; 2008 Oct; 113(7):1614-22. PubMed ID: 18704990
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success.
Vogl TJ; Naguib NN; Nour-Eldin NE; Bechstein WO; Zeuzem S; Trojan J; Gruber-Rouh T
Int J Cancer; 2012 Aug; 131(3):733-40. PubMed ID: 21976289
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
Cercek A; Boerner T; Tan BR; Chou JF; Gönen M; Boucher TM; Hauser HF; Do RKG; Lowery MA; Harding JJ; Varghese AM; Reidy-Lagunes D; Saltz L; Schultz N; Kingham TP; D'Angelica MI; DeMatteo RP; Drebin JA; Allen PJ; Balachandran VP; Lim KH; Sanchez-Vega F; Vachharajani N; Majella Doyle MB; Fields RC; Hawkins WG; Strasberg SM; Chapman WC; Diaz LA; Kemeny NE; Jarnagin WR
JAMA Oncol; 2020 Jan; 6(1):60-67. PubMed ID: 31670750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
